BR112012011262A2 - sistemas e métodos para detectar a presença de um estado biológico usando aglomeração - Google Patents

sistemas e métodos para detectar a presença de um estado biológico usando aglomeração

Info

Publication number
BR112012011262A2
BR112012011262A2 BR112012011262A BR112012011262A BR112012011262A2 BR 112012011262 A2 BR112012011262 A2 BR 112012011262A2 BR 112012011262 A BR112012011262 A BR 112012011262A BR 112012011262 A BR112012011262 A BR 112012011262A BR 112012011262 A2 BR112012011262 A2 BR 112012011262A2
Authority
BR
Brazil
Prior art keywords
genetic element
input values
samples
input
agglomeration
Prior art date
Application number
BR112012011262A
Other languages
English (en)
Portuguese (pt)
Inventor
Arevalo Reyes Antonio
Alan Gustafson Erik
Lu Jiuliu
Steven Riley John
Wang Zihua
Original Assignee
Beckman Coulter Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Coulter Inc filed Critical Beckman Coulter Inc
Publication of BR112012011262A2 publication Critical patent/BR112012011262A2/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112012011262A 2009-11-13 2010-11-12 sistemas e métodos para detectar a presença de um estado biológico usando aglomeração BR112012011262A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26114709P 2009-11-13 2009-11-13
PCT/US2010/056455 WO2011060222A2 (en) 2009-11-13 2010-11-12 Systems and methods for detecting the presence of a biological status using clustering

Publications (1)

Publication Number Publication Date
BR112012011262A2 true BR112012011262A2 (pt) 2019-09-24

Family

ID=43806873

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012011262A BR112012011262A2 (pt) 2009-11-13 2010-11-12 sistemas e métodos para detectar a presença de um estado biológico usando aglomeração

Country Status (8)

Country Link
US (3) US8442924B2 (enExample)
EP (1) EP2499591A2 (enExample)
JP (2) JP5907880B2 (enExample)
KR (1) KR20120101065A (enExample)
CN (1) CN102713919B (enExample)
BR (1) BR112012011262A2 (enExample)
RU (1) RU2012124051A (enExample)
WO (1) WO2011060222A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010076013A1 (de) * 2008-12-30 2010-07-08 Qiagen Gmbh Verfahren zum nachweis methicillin-resistenter staphylococcus aureus (mrsa)-stämme
EP2499591A2 (en) 2009-11-13 2012-09-19 Beckman Coulter, Inc. Systems and methods for detecting the presence of a biological status using clustering
EP2617836A1 (en) * 2012-01-23 2013-07-24 Steffen Mergemeier Method for detecting a methicillin resistant coagulase positive Staphylococcus aureus strain
EP2887245A1 (en) * 2013-12-20 2015-06-24 Dassault Systèmes A computer-implemented method for designing a biological model
EP4354446A4 (en) * 2021-06-09 2025-05-28 Kyoto University INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD AND PROGRAM

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US6335184B1 (en) * 1993-07-23 2002-01-01 Bio-Rad Laboratories, Inc. Linked linear amplification of nucleic acids
US5702895A (en) 1995-01-19 1997-12-30 Wakunaga Seiyaku Kabushiki Kaisha Method and kit for detecting methicillin-resistant Staphylococcus aureus
JP3957338B2 (ja) 1996-02-23 2007-08-15 株式会社カイノス 診断薬
US6358519B1 (en) * 1998-02-16 2002-03-19 Ruth S. Waterman Germ-resistant communication and data transfer/entry products
CA2378032A1 (en) * 1999-08-04 2001-02-15 Pharmacia & Upjohn Company Crystallization and structure determination of staphylococcus aureus udp-n-acetylenolpyruvylglucosamine reductase (s. aureus murb)
JP2004531251A (ja) * 2001-03-15 2004-10-14 シュレンツェル，ジャック メチシリン耐性黄色ブドウ球菌（ｍｒｓａ）の直接検出の方法
US20020188424A1 (en) * 2001-04-20 2002-12-12 Grinstein Georges G. Method and system for data analysis
FR2844807B1 (fr) * 2002-09-23 2005-11-11 Rambach Alain Procede de detection de microorganismes resistants a la meticilline
EP2574400B1 (en) * 2003-02-05 2016-09-28 Iquum, Inc. Sample processing
ES2260578T3 (es) 2003-11-07 2006-11-01 FEDERAL REP GERMANY REPR BY MINISTRY HEALTH & SOC SECURITY, THE LATTER REPR BY PRES ROBERT KOCH INS. Metodo para detectar staphylococcus aureus resistente a la meticilina (mrsa).
EP1541696A1 (en) 2003-12-09 2005-06-15 Institut Pasteur A DNA macro-array for staphylococcus aureus identification and typing
EP1776458A2 (en) 2004-07-30 2007-04-25 Agencourt Bioscience Corporation Methods of isolating nucleic acids using multifunctional group-coated solid phase carriers
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
GB0504537D0 (en) * 2005-03-04 2005-04-13 Blaze Venture Technologies Ltd Method and device for bacterial sampling
US20070196820A1 (en) * 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US7838221B2 (en) * 2005-10-11 2010-11-23 Geneohm Sciences, Inc. Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA)
CA2651510C (en) 2006-05-12 2016-08-09 Cepheid Dna recombination junction detection
US8936791B2 (en) * 2006-10-18 2015-01-20 Biomerieux Method for in vitro diagnosis of PVL-producing Staphylococcus aureus
US8017337B2 (en) 2007-04-19 2011-09-13 Molecular Detection, Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
US7888075B2 (en) * 2007-07-31 2011-02-15 Quest Diagnostics Investments Incorporated Detection of methicillin-resistant and methicillin-sensitive Staphylococcus aureus in biological samples
US8229678B2 (en) * 2008-07-25 2012-07-24 Beckman Coulter, Inc. Methods and systems for transforming particle data
US8000940B2 (en) * 2008-10-08 2011-08-16 Beckman Coulter, Inc. Shape parameter for hematology instruments
US8154273B2 (en) * 2008-10-10 2012-04-10 Beckman Coulter, Inc. Detecting and handling coincidence in particle analysis
US8581927B2 (en) * 2008-11-04 2013-11-12 Beckman Coulter, Inc. Multidimensional particle analysis data cluster reconstruction
WO2010056740A1 (en) * 2008-11-13 2010-05-20 Beckman Coulter, Inc. Method of correction of particle interference to hemoglobin measurement
EP2499591A2 (en) 2009-11-13 2012-09-19 Beckman Coulter, Inc. Systems and methods for detecting the presence of a biological status using clustering

Also Published As

Publication number Publication date
US9519751B2 (en) 2016-12-13
US20170140096A1 (en) 2017-05-18
JP2015165413A (ja) 2015-09-17
KR20120101065A (ko) 2012-09-12
RU2012124051A (ru) 2013-12-20
WO2011060222A9 (en) 2011-07-14
JP5907880B2 (ja) 2016-04-26
CN102713919B (zh) 2016-07-06
US20130196334A1 (en) 2013-08-01
US8442924B2 (en) 2013-05-14
EP2499591A2 (en) 2012-09-19
JP2013510579A (ja) 2013-03-28
WO2011060222A2 (en) 2011-05-19
CN102713919A (zh) 2012-10-03
US20110131159A1 (en) 2011-06-02

Similar Documents

Publication Publication Date Title
Traversi et al. Precision medicine and public health: new challenges for effective and sustainable health
Price et al. Different measures of “genome-wide” DNA methylation exhibit unique properties in placental and somatic tissues
Coe et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay
Sørensen et al. The predictive value of miR-16,-29a and-134 for early identification of gestational diabetes: a nested analysis of the DALI cohort
MX2016016904A (es) Analisis de secuencias de acidos nucleicos.
GB2568608A (en) Personalized genetic testing
Bressan et al. The Foundational Data Initiative for Parkinson Disease: Enabling efficient translation from genetic maps to mechanism
MY170164A (en) Aptamer-based multiplexed assays
BR112015022322A2 (pt) sistemas e métodos para detecção de células com o uso de partículas de transdução projetadas
Andrikovics et al. Current trends in applications of circulatory microchimerism detection in transplantation
BR112012011262A2 (pt) sistemas e métodos para detectar a presença de um estado biológico usando aglomeração
Cheng et al. Increased Alu RNA processing in Alzheimer brains is linked to gene expression changes
Brockley et al. Sequence-based platforms for discovering biomarkers in liquid biopsy of non-small-cell lung cancer
Palmieri et al. Functional implications of microRNAs in Crohn’s disease revealed by integrating microRNA and messenger RNA expression profiling
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
Urbas et al. Relevance of MicroRNA200 family and MicroRNA205 for epithelial to mesenchymal transition and clinical outcome in biliary tract cancer patients
López-Armas et al. Leukocyte telomere length predicts severe disability in relapsing-remitting multiple sclerosis and correlates with mitochondrial DNA copy number
Yavropoulou et al. A role for circular non-coding RNAs in the pathogenesis of sporadic parathyroid adenomas and the impact of gender-specific epigenetic regulation
WO2009017879A3 (en) Image portion identification methods, image parsing methods, image parsing systems, and articles of manufacture
Talay et al. Addendum: IgE+ memory B cells and plasma cells generated through a germinal-center pathway
BR112016003058A2 (pt) composições e métodos para análise multiplex de ácidos nucleicos nras e braf
Penington et al. Influence of fecal collection conditions and 16S rRNA gene sequencing protocols at two centers on human gut microbiota analysis
de Oliveira et al. Can Global DNA Methylation Be Influenced by Polymorphisms in Genes Involved in Epigenetic Mechanisms? A Review
Shankar-Hari et al. How might a diagnostic microRNA signature be used to speed up the diagnosis of sepsis?
Driedonks et al. Viral and host small RNA transcriptome analysis of SARS-CoV-1 and SARS-CoV-2-infected human cells reveals novel viral short RNAs

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.